VG2D Pharma was at InnoRem, where Prof. Gérard and Dr. Velard presented the latest updates on our R&D roadmap.

The VG2D Pharma team shared their ambitious vision for health equity with Grand Est, highlighting how the company plans to turn their slogan, “Innovation with Broader Reach,” into a tangible

Following an outlicensing agreement with SATT Nord, a public entity managing intellectual property for the University of Reims Champagne-Ardenne (URCA), VG2D now holds full rights to exploit the molecule. The